These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3503673)

  • 1. Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis.
    Harris M; Nora L; Tanner CM
    Clin Neuropharmacol; 1987 Apr; 10(2):186-9. PubMed ID: 3503673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of neuroleptic malignant syndrome.
    Lazarus A
    Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbidopa/levodopa in the treatment of neuroleptic malignant syndrome.
    Shoop SA; Cernek PK
    Ann Pharmacother; 1997 Jan; 31(1):119. PubMed ID: 8997480
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period.
    Mizuta E; Yamasaki S; Nakatake M; Kuno S
    Neurology; 1993 May; 43(5):1048-9. PubMed ID: 7605396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical management of neuroleptic malignant syndrome.
    Susman VL
    Psychiatr Q; 2001; 72(4):325-36. PubMed ID: 11525080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of neuroleptic malignant syndrome--a series of eight cases.
    Kurien T; Rajeev KK; Abraham OC; Archana S; Cherian AM
    J Assoc Physicians India; 1993 Feb; 41(2):91-3. PubMed ID: 8101521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic malignant syndrome].
    Reingardiene D
    Medicina (Kaunas); 2002; 38(1):1-5. PubMed ID: 12474710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral encephalitis complicated by neuroleptic malignant syndrome in a 7-year-old girl.
    Hillis RE; Lee DA
    Pediatr Emerg Care; 2003 Apr; 19(2):99-100. PubMed ID: 12698035
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause.
    Figà-Talamanca L; Gualandi C; Di Meo L; Di Battista G; Neri G; Lo Russo F
    Neurology; 1985 Feb; 35(2):258-61. PubMed ID: 3969217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neuroleptic malignant syndrome: agent and host interaction.
    Shalev A; Munitz H
    Acta Psychiatr Scand; 1986 Apr; 73(4):337-47. PubMed ID: 2873715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous administration of lisuride in the treatment of neuroleptic malignant syndrome.
    de Mari M; Lamberti P; Simone F; Iliceto G; Federico F; Ferrari E
    Funct Neurol; 1991; 6(3):285-8. PubMed ID: 1683852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy.
    Perry D; Birthi P; Salles S; McDowell S
    PM R; 2012 May; 4(5):383-4. PubMed ID: 22613365
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible central effect of dantrolene sodium in neuroleptic malignant syndrome.
    Yamawaki S; Yanagawa K; Morio M; Mori K
    J Clin Psychopharmacol; 1986 Dec; 6(6):378-9. PubMed ID: 3805336
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional hyperthermia due to central dopaminergic impairment.
    Di Rosa AE; Morgante L; Coraci MA; Crisafulli A; Cacciola G; Di Stefano G; Meduri M; Di Perri R
    Funct Neurol; 1988; 3(2):211-5. PubMed ID: 2900182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prolonged neuroleptic malignant syndrome after Haloperidol injection].
    Wystub N; Heymel S; Fritzenwanger M; Schulze PC; Pfeifer R
    Med Klin Intensivmed Notfmed; 2018 Apr; 113(3):212-216. PubMed ID: 28752347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome.
    Rampertaap MP
    South Med J; 1986 Mar; 79(3):331-6. PubMed ID: 3513330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
    Gönner F; Baumgartner R; Schüpbach D; Merlo MC
    Psychopharmacology (Berl); 1999 Jun; 144(4):416-8. PubMed ID: 10435416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
    Yamawaki Y; Ogawa N
    Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy.
    Tenenbein M
    Pediatr Neurosci; 1985-1986; 12(3):161-4. PubMed ID: 3870437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.